1 week Ago By ABMN Staff
GAMMA Investing LLC raised its holdings in shares of Zoetis Inc. ( NYSE:ZTS – Free Report ) by 36.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.
The institutional investor owned 11,862 shares of the company’s stock after buying an additional 3,165 shares during the quarter. GAMMA Investing LLC’s holdings in Zoetis were worth $1,933,000 as of its most recent filing with the Securities & Exchange Commission. A number of other institutional investors have also added to or reduced their stakes in the business.
Simplify Asset Management Inc. purchased a new position in shares of Zoetis during the third quarter worth about $11,684,000. JPMorgan Chase & Co.
lifted its position in Zoetis by 10.6% during the third quarter. JPMorgan Chase & Co.
now owns 2,916,539 shares of the company’s stock valued at $569,834,000 after purchasing an additional 279,092 shares during the last quarter. B&L Asset Management LLC purchased a new position in Zoetis in the 3rd quarter worth approximately $563,000. Geode Capital Management LLC increased its holdings in shares of Zoetis by 1.
8% in the 3rd quarter. Geode Capital Management LLC now owns 10,427,760 shares of the company’s stock worth $2,030,813,000 after buying an additional 185,364 shares during the last quarter. Finally, Dai ichi Life Insurance Company Ltd raised its position in shares of Zoetis by 16.
3% during the 3rd quarter. Dai ichi Life Insurance Company Ltd now owns 74,499 shares of the company’s stock valued at $14,556,000 after buying an additional 10,427 shares in the last quarter. 92.
80% of the stock is currently owned by institutional investors. Analysts Set New Price Targets Several research analysts recently issued reports on ZTS shares. UBS Group began coverage on shares of Zoetis in a research report on Monday, December 9th.
They issued a “neutral” rating and a $196.00 target price for the company. Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a report on Monday, December 2nd.
Leerink Partners began coverage on Zoetis in a research report on Monday, December 2nd. They set an “outperform” rating and a $215.00 price objective on the stock.
Stifel Nicolaus boosted their target price on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday, September 18th.
Finally, JPMorgan Chase & Co. increased their price target on shares of Zoetis from $225.00 to $230.
00 and gave the company an “overweight” rating in a research report on Friday, October 11th. One research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.
com, the stock presently has an average rating of “Buy” and a consensus target price of $215.22. Zoetis Stock Down 0.
2 % Shares of Zoetis stock opened at $162.61 on Friday. The company has a debt-to-equity ratio of 1.
26, a quick ratio of 2.27 and a current ratio of 3.69.
Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.
53. The company’s 50 day moving average price is $173.74 and its 200-day moving average price is $180.
39. The stock has a market capitalization of $73.36 billion, a price-to-earnings ratio of 30.
57, a P/E/G ratio of 2.91 and a beta of 0.89.
Zoetis ( NYSE:ZTS – Get Free Report ) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.
46 by $0.12. The business had revenue of $2.
40 billion for the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a net margin of 26.
55% and a return on equity of 51.98%. The company’s revenue was up 11.
6% on a year-over-year basis. During the same quarter last year, the firm earned $1.36 EPS.
Equities research analysts forecast that Zoetis Inc. will post 5.9 EPS for the current year.
Zoetis Increases Dividend The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share.
This is a positive change from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, January 21st.
This represents a $2.00 dividend on an annualized basis and a yield of 1.23%.
Zoetis’s dividend payout ratio is presently 37.59%. About Zoetis ( Free Report ) Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally.
The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. Further Reading Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc.
( NYSE:ZTS – Free Report ). Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter .
.
